Hebei: Innovative drug enters Phase III clinical trial to give 5 million yuan reward

　　Medicine Network November 29 Reporters learned from the Hebei provincial government, in order to comprehensively improve the scale and quality of the development of the biopharmaceutical industry in Hebei Province, Hebei Province issued "on supporting the high-quality development of the biopharmaceutical industry a number of policies." Among them, in support of innovative drug research and development, to enter phase III clinical trial research of innovative drugs, to give 5 million yuan of provincial strategic emerging industries special fund awards in accordance with the policy, Hebei strongly supports the research and development of innovative drugs for all kinds of market subjects registered in the administrative area of Hebei Province with independent legal personality, engaged in and research and development, production and service Among them, to support the chinese traditional medicine varieties to increase the secondary development of indications, evidence-based medical research, merit-based inclusion in the provincial science and technology plan to give up to 1 million yuan of provincial science and technology special funding support For innovative drugs to enter Phase II clinical trial research, 3 million yuan of provincial strategic emerging industries special funds award For the new modified drugs that enter phase III clinical trials, 2 million yuan will be awarded special funds for strategic emerging industries in the province in support of the industrialization of innovative drugs, Hebei Province to obtain the approval of pharmaceutical production of innovative drugs and land in the province of the industrialization projects, priority into the province's high-tech industrialization project plan, to give no more than 30% of the project fixed asset investment, up to a maximum of 50 million yuan of provincial strategic emerging industries special funds subsidies For the industrialization projects of improved new drugs that have obtained the batch of drug production and land in the province, priority shall be given to the provincial high-tech industrialization project plan, and special funds shall be granted for the province's strategic emerging industries not exceeding 20% of the fixed asset investment of the project and up to a maximum of 20 million yuan In addition, in support of the listing of chemical generics, biosimilardrugs, Hebei Province, the first three chemical generics and biosimilardrugs that have passed a consistent evaluation, the first three obtained the batch of pharmaceutical production and land production projects in the province, priority into the provincial high-tech industrialization project plan, and to give no more than 20% of the project fixed asset investment, up to a maximum of 20 million yuan of the province's strategic emerging industries special fund subsidies.